Back to Awarded Treatment Trials
Awarded Trial: 04T-536
Grant ID
04T-536
Illness
Schizophrenia
Primary Drug/Intervention
Folic Acid
Primary Dosage
4 mg
Secondary Drug Intervention
B-12
Secondary Dosage
1mg
Other Drug/Intervention
Pyridoxine
Other Dosage
50mg
Status
Completed
Investigator
Greenberg
Sample Size
90
Duration of Study Period for Each Subject
12 weeks
Outcome Measurements
PANSS, CDSS, Cognitive Battery
Results
There was no significant effect of the vitamin combination compared to placebo. Fifty patients were randomized and 42 patients remained in the trial long enough to be included in data analysis.
Publication
N/A
Link
N/A
PI Name
William Greenberg
Degree
MD
Center
Nathan S. Kline Institute for Psychiatric Research
Institution
Nathan S. Kline Institute for Psychiatric Research, Dept. of Psychiatry
Address
140 Old Orangeburg Road, Bldg. 35
City or Town
Orangeburg
State or Province
NY
Zip or Postal Code
10962
Country
USA
Email Address
greenberg@nki.rfmh.org